Tumor biology and prognostic factors in renal cell carcinoma. - Wikidata - awgldk - TriplyDB

Tumor biology and prognostic factors in renal cell carcinoma.

Tumor biology and prognostic factors in renal cell carcinoma.

http://www.wikidata.org/entity/Q37846387

about

Renal cell cancer: overview of the current therapeutic landscape.Integration of multimodal RNA-seq data for prediction of kidney cancer survival.Clinico-pathological prognostic factors of renal cell carcinoma: A 15-year review from a single center in Greece Insulin receptor expression in clear cell renal cell carcinoma and its relation to prognosis.TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma.DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells.Increased expression of the very low-density lipoprotein receptor mediates lipid accumulation in clear-cell renal cell carcinoma.Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidence.Cancer stem cell-like side population cells in clear cell renal cell carcinoma cell line 769P.Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma The expression and role of protein kinase C (PKC) epsilon in clear cell renal cell carcinoma.Systemic adjuvant therapies in renal cell carcinoma Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells Prognostic markers in renal cell carcinoma: A focus on the 'mammalian target of rapamycin' pathway Current status of targeted therapy for advanced renal cell carcinoma Overexpression of IL-32 is a novel prognostic factor in patients with localized clear cell renal cell carcinoma Personalized tumor response assessment in the era of molecular medicine: cancer-specific and therapy-specific response criteria to complement pitfalls of RECIST Renal cell neoplasms contain shared tumor type-specific copy number variations.Insulin-like growth factor-1 signaling in renal cell carcinoma Phospho-4e-BP1 and eIF4E overexpression synergistically drives disease progression in clinically confined clear cell renal cell carcinoma Expression and prognostic significance of zinc fingers and homeoboxes family members in renal cell carcinoma.Preclinical Modeling of Tumor Growth and Angiogenesis Inhibition to Describe Pazopanib Clinical Effects in Renal Cell Carcinoma.Interleukin-1β mediates metalloproteinase-dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein β Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial Klotho plays a critical role in clear cell renal cell carcinoma progression and clinical outcome Ovatodiolide Targets β -Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma.Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas.CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma.The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways.Influence of VEGFR single nucleotide polymorphisms on the efficacy of sunitinib therapy against renal cell carcinoma.The expression and role of tyrosine kinase ETK/BMX in renal cell carcinoma Establishing the carcinogenic risk of immunomodulatory drugs.The role of minimally invasive surgery in multifocal renal cell carcinoma.Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma.Estradiol via estrogen receptor beta influences ROS levels through the transcriptional regulation of SIRT3 in human seminoma TCam-2 cells.Contemporary Status of Percutaneous Ablation for the Small Renal Mass.Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration.The plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling β1 integrin internalization and recycling.Sunitinib in metastatic renal cell carcinoma (mRCC): a developing country experience. Do our patients behave differently than the Western patients?

P2860

Q30248354-298A14C7-98E7-4247-852E-A5B54D4FD394 Q31121966-4420C476-A5DA-4832-AA6A-9282DACA400A Q33614217-CADF59BA-5274-4C26-BB1B-497FEA989D3D Q33822523-01DDE556-4A91-4CB8-ADD9-3060BCC0CC2B Q34365715-FC13AD3E-0996-49D6-957C-FDDC5FDA8FBF Q34374689-5A5017EF-EB63-4D2A-915F-49543EBFDBBE Q34489747-4AF55CC3-EEEA-41D2-B10A-76FC3A702C62 Q34627163-D45627FF-5C32-4F02-B570-8C3C50253739 Q34847829-A152F031-1B7D-458C-9C5E-AF7077F11601 Q34995476-209983FA-5981-458A-B2A9-73B879F2EBF5 Q35241051-23CA1A55-D033-4432-9172-BE41C9FAE265 Q35344603-B3932BE7-A54B-44C5-8C0E-0333699B03AC Q35569322-8F2E6DD1-3B3D-42FA-A080-05CED0C0B970 Q35678417-43A2C215-9ADD-47B2-9CAF-9FA12C7614BB Q35838273-9B75FEC1-3F31-48B3-B3A7-9736829C325D Q35903850-1D076A2F-C7A6-48F5-9F09-B065F48595AA Q35995303-E03658D6-07AD-49AA-A0D3-BB670ACB3955 Q36015295-63264947-4EE7-4FCA-B869-FE150EEC5BB2 Q36044617-E3B5E345-0F31-4939-B74A-9EEACA58C7CE Q36074111-F8453E60-EE25-47C2-BA29-1820241BE5B0 Q36250674-1363992C-8BB3-4E52-B2C2-CA3459755AF7 Q36267604-A68B5635-0AB5-4695-8660-D64208360A3B Q36473115-79BBDA2F-88BD-49EE-BD42-75453E2A7FEB Q36530615-33D55622-6224-45D1-AE33-5A68B124872A Q36726204-78EE2E3C-550F-4134-A89E-FDF9EBFEF062 Q36881226-A33D3DF8-1163-45CC-A754-F22D62CEC90D Q36916021-8E1E5A22-BC45-4C27-86FC-B018F712EEEC Q37040588-81569BE4-1587-4959-885F-7E13F5FE2095 Q37054587-F02E3C28-B388-4A43-BE54-00D508B3501D Q37112443-0EBB9606-E2BE-46D7-AAAF-BC6E29F3EB16 Q37594014-B76A2E93-1D97-469C-9837-304161723B57 Q37699758-9B2260B6-324B-49D5-8C25-13C9C47B97A2 Q37959333-084627FD-19FC-4F3A-90B3-07D4ACC2B337 Q38005933-E09136C9-FC63-45F4-83F3-388633B060A2 Q38543085-922B7812-5423-4063-B543-2ACB58972BF7 Q38689132-C2CF21E1-12BD-4BE9-8DAF-502A92CFB76C Q38732390-939E86FD-23AA-4FFF-9697-177575281AD8 Q38979602-87D9A9F9-5B67-4BD2-8D56-D6CB018A105C Q39247356-8B3A3A31-4CE7-40D3-8027-88457FBAD876 Q39569666-5F3642D5-60EE-472B-B84E-FA342B71316C

P2860

Tumor biology and prognostic factors in renal cell carcinoma.

http://www.wikidata.org/entity/Q37846387

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tumor biology and prognostic factors in renal cell carcinoma.

@en

Tumor biology and prognostic factors in renal cell carcinoma.

@nl

type

label

Tumor biology and prognostic factors in renal cell carcinoma.

@en

Tumor biology and prognostic factors in renal cell carcinoma.

@nl

prefLabel

Tumor biology and prognostic factors in renal cell carcinoma.

@en

Tumor biology and prognostic factors in renal cell carcinoma.

@nl

P1433

Q37846387-6BD11F85-2C40-45BF-B870-952D419CACED

P1476

Q37846387-1AE9A4C4-5D85-444C-AD0E-EA27271308FE

P2093

Q37846387-07E22788-9C9D-4BEF-B456-5E700C89FA3D

Q37846387-1DB5FEDF-3748-4196-BFAF-7E3F05C6CECA

Q37846387-D77D0F03-EEE5-4E58-B1E6-BB1C4AE69424

P2860

Q37846387-06E1163B-B86D-423C-9551-78E87FA277F5

Q37846387-07973B61-3AC2-4806-B442-18C24A024111

Q37846387-0A0751BD-1430-4E8C-9338-9C49DDBEB8B4

Q37846387-11950D89-4DFE-41E3-83F9-FE32A0FB60F6

Q37846387-187F0078-F1C0-4F23-98C3-53A701340BEF

Q37846387-195A6B33-6CE9-4DFF-ADBA-B0F09D71C068

Q37846387-1DFF2CCC-C471-4DDF-9595-165B6E9A10E6

Q37846387-23E0FD3E-C3BE-4E18-A49F-ED5CFB89A58D

Q37846387-25768860-EEC7-4BA7-BC76-BDC28828681E

Q37846387-2747A51C-AE32-4219-AE16-51D0532E0307

P304

Q37846387-DB177699-7903-444E-9AB9-FF4DF15E1A5F

P31

Q37846387-FC483847-A81A-4F8A-BB36-949972105EAD

P356

Q37846387-B46CF8FB-A3C3-4A4F-882F-E0BE88BD0EA7

P478

Q37846387-8DB0E986-C7C6-4EA2-B114-F1BCB35AB932

P577

Q37846387-A84DBEB0-2083-4F7B-8799-852CB64F381A

P5875

Q37846387-24A8A96E-0798-49C7-8C4B-59B8C4953EBD

P698

Q37846387-B46D8A86-CD07-4208-B1A0-09A464892D89

P932

Q37846387-2752C25D-4D57-43C6-B0DC-55F8EF6F6F47

P356

THEONCOLOGIST.2011-S2-04

P1433

P1476

Tumor biology and prognostic factors in renal cell carcinoma.

@en

P2093

Allan J Pantuck

http://www.w3.org/2001/XMLSchema#string

Arie S Belldegrun

http://www.w3.org/2001/XMLSchema#string

David S Finley

http://www.w3.org/2001/XMLSchema#string

P2860

Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling

Identification and characterization of a novel folliculin-interacting protein FNIP2

Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C

The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins

Cancer statistics, 2010

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

Defining the role of mTOR in cancer

Upstream and downstream of mTOR

Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study

P304

4-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2011-S2-04

http://www.w3.org/2001/XMLSchema#string

P478

16 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50264819

http://www.w3.org/2001/XMLSchema#string

P698

21346035

http://www.w3.org/2001/XMLSchema#string

P932

3868202

http://www.w3.org/2001/XMLSchema#string